Skip to main navigation
Top bar
logo

Ayala - Corp Menu

  • Who We Are
    • Our Mission
    • Meet Our Team
  • Pipeline
    • Our Approach
    • Gamma Secretase Inhibitors (GSIs)
    • Investigational Therapies: AL101 and AL102
  • Clinical Trials
    • Clinical Privacy Notice
  • Medical Professionals
  • Patients & Caregivers
    • Science Explained
    • Participating In Clinical Trials
    • Expanded Access Policy
    • Patient Resources
  • Investors & Media
    • Investors
    • News Releases
    • Events & Presentations
    • Financial Information
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Resources
      • Contact IR
  • Partners

SEC Filing Details

Ayala - Financial Info Submenu

  • SEC Filings
  • Quarterly Results

SEC Filing Details

Document Details

Form
EFFECT
Filing Date
Jun 15, 2021
Document Date
Jun 15, 2021
Form Description
EFFECT
Filing Group
Other
Company
Ayala Pharmaceuticals
Issuer
OLD AYALA, INC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Ayala - Investor Tools

  • Print Page
  • RSS Feeds
  • Contact IR
US Address
1007 North Orange Street, 4th Floor,
Wilmington, DE 19801
+1-857-444-0553
 
9 Deer Park Drive, Suite K-1
Monmouth Junction, NJ 08852
 
Israel Address
4 Oppenheimer Street, Rehovot
7670104 Israel
+972-8-373-1541
Investor Relations
ir@ayalapharma.com
 
Questions
info@ayalapharma.com
 
Careers
jobs@ayalapharma.com
 
© Ayala Pharmaceuticals. All rights reserved. Privacy Policy | Terms of Use
  • Facebook
  • Twitter
  • LinkedIn
  • Google+